Glenmark gets nod from Russian Ministry of Healthcare to market Montlezir film-coated tablets | | Udaipur News | Udaipur Latest News | udaipur local news । Udaipur Updates
Home / BUSINESS / Glenmark gets nod from Russian Ministry of Healthcare to market Montlezir film-coated tablets

Glenmark gets nod from Russian Ministry of Healthcare to market Montlezir film-coated tablets

Glenmark Pharmaceuticals has received approval from the Ministry of Healthcare, Russia to market Montlezir (Levocetirizine Dihydrochloride 5mg + Montelukast Sodium 10mg) film‐coated tablets as a prescription product for the treatment of seasonal and perennial allergic rhinitis in patients above 15 years of age. Montlezir is expected to be available in the Russian market in Q3 FY 2019‐20.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Please share this news